Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01815567 · ClinicalTrials.gov registry record

DETECT and Retinal Outcomes in Hypertension

A clinical trial of Hypertension and Cognitive Impairment, sponsored by Emory University.

Completed
Registry status
234
Enrollment target
1
Study location

NCT01815567 is a study of Hypertension and Cognitive Impairment that has completed, run by Emory University. The registered enrollment target is 234 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01815567, a study of Hypertension and Cognitive Impairment, has completed, sponsored by Emory University.

COMPLETED
Registry status
234 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to study the impact of blood pressure on cognitive performance.

Study Locations (1)

Georgia

  • Grady Memorial Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 234 participants
Start Date 2012-11
Est. Completion 2020-07-15

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT01815567

The ClinicalTrials.gov registry entry for NCT01815567 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 234 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (93% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT01815567 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT01815567 about?

NCT01815567 is a clinical study titled "DETECT and Retinal Outcomes in Hypertension". The purpose of this study is to study the impact of blood pressure on cognitive performance.

What is the current status of trial NCT01815567?

This trial is currently completed. The enrollment target is 234 participants. The study started on 2012-11. Estimated completion is 2020-07-15.

What conditions does trial NCT01815567 study?

This clinical trial studies the following conditions: Hypertension, Cognitive Impairment, Retinal Disorder.

Who is sponsoring clinical trial NCT01815567?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01815567 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.